Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 15/20 | 0.67 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.66 |
| ▸ | NQO2 | P16083 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6254856 | 0.94 | MTNR1A (0.69) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL9131349 | 0.93 | MTNR1A (0.69) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL14615455 | 0.91 | MTNR1A (0.61) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL5339923 | 0.85 | MTNR1A (0.71) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL27450734 | 0.82 | MTNR1A (0.70) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8065738 | 0.81 | MTNR1A (0.52) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961285 | 0.81 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL6075677 | 0.81 | MTNR1A (0.72) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL6247137 | 0.81 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL29493844 | 0.81 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0562956-B1 | Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1995-09-27 | — | — | EP | claimed |
| US-5420158-A | Melatonin activity | ADIR ET COMPAGNIE (FR) | 1995-05-30 | — | — | US | claimed |
| EP-0562956-A1 | Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1993-09-29 | — | — | EP | claimed |
| JP-6049011-A | — | — | None | — | — | JP | disclosed |
| CN-1155562-C | Novel naphthalene compounds, process for their preparation and pharmaceutical compositions containing them | ɪά��ʵ���� | 2004-06-30 | — | — | CN | disclosed |
| US-6143789-A | ENANTIOMORPHS | ADIR ET COMPAGNIE (FR) | 2000-11-07 | — | — | US | disclosed |
| CN-1221734-A | Novel naphthalene compounds, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1999-07-07 | — | — | CN | disclosed |
| EP-0919541-A1 | Naphthalene compounds, process for their preparation and their pharmaceutical compositions | ADIR ET COMPAGNIE (FR) | 1999-06-02 | — | — | EP | disclosed |
| US-5616614-A | USEFUL IN TREATMENT OF DISORDERS LINKED TO ABNORMAL MELATONIN ACTIVITY | ADIR ET COMPAGNIE (FR) | 1997-04-01 | — | — | US | disclosed |
| EP-0562956-B1 | Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1995-09-27 | — | — | EP | disclosed |
| US-5420158-A | Melatonin activity | ADIR ET COMPAGNIE (FR) | 1995-05-30 | — | — | US | disclosed |
| JP-H0649011-A | NEW NAPHTHYLALKYLAMINE, ITS PREPARATION AND PHERMACEUTICAL COMPOSITION CONTAINING THE SAME | ADIR | 1994-02-22 | — | — | JP | disclosed |
| EP-0562956-A1 | Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1993-09-29 | — | — | EP | disclosed |